Your Unread Messages in Pharma News
See All >> Messages include industry-sponsored communications and special communications from MDLinx241 UCB and Astellas announce agreement to jointly develop and commercialize Cimzia (certolizumab pegol) in Japan Full Text UCB, February 6, 2013
242 Minnesota Timberwolves Star Ricky Rubio Teams Up with Medtronic Foundation to Save Young Lives from Sudden Cardiac Arrest Full Text Medtronic, February 6, 2013
243 Shire reaches agreement in principle with U.S. Government Shire, February 5, 2013
244 Primus Capital Picks up Emmi Solutions Health Data Management, February 4, 2013
245 HIMSS13: Coming Soon: EHR Self-Assessment Safety Guides Health Data Management, February 4, 2013
246 Watson Acquires Uteron Pharma SA Full Text Actavis, February 4, 2013
247 Watson Pharmaceuticals, Inc. is Now Actavis, Inc. Full Text Actavis, February 4, 2013
248 Watson Confirms Opana ER Patent Challenge Full Text Actavis, February 4, 2013
249 Teva Announces Termination of Agreements with CureTech Full Text Teva Pharmaceutical Industries, February 1, 2013
250 UCB to enter into an asset purchasing agreement with Exemed Pharmaceuticals for its Indian manufacturing facility Full Text UCB, February 1, 2013
251 Cimzia, the only PEGylated anti-TNF, approved in Europe and available in a syringe designed in partnership with OXO Good Grips Full Text UCB, January 31, 2013
252 Liam Condon: “Innovation and partnerships needed to achieve food security” Full Text BayNews International, January 31, 2013
253 Zytoprotec Raises EUR 2 Million in Financing from Baxter Ventures B3C newswire, January 30, 2013
254 Oxford Immunotec and Lophius Biosciences Sign Licensing and Collaboration Agreements B3C newswire, January 30, 2013
255 GSK and Biological E. announce joint venture to develop combination vaccine for India and other developing countries Full Text GlaxoSmithKline, January 29, 2013
256 Rotary International and PhRMA team up for The Worlds Biggest Commercial Full Text PhRMA, January 28, 2013
257 Major Shareholder Announcement Full Text Genmab, January 25, 2013
258 Pfizer Partnership Organizations Significantly Benefit From Pfizers Global Health Fellows Program Full Text Pfizer, January 23, 2013
259 Teva Enters Agreement with Handok to Establish Business Venture with Significant Presence in Korean Pharmaceutical Market Full Text Teva Pharmaceutical Industries, January 23, 2013
260 GSK signs up to UK Governments Public Health Responsibility Deal Full Text GlaxoSmithKline, January 23, 2013
1 Sanofi strengthens its French-German partnership on the occasion the French-German Week for Science and Alumni Sanofi, April 16, 2013 Free full text
2 Actavis and Valeant Announce Actavis as Exclusive Authorized Generic Marketer of Zovirax Ointment; Co-Promotion Agreements on Zovirax Cream and Cordran Tape Valeant Pharmaceuticals International, April 8, 2013 Free full text
3 Actavis Announces OxyContin Patent Challenge Settlement Actavis, May 1, 2013 Free full text
4 Actavis Reaches Agreements with Valeant to Launch Generic Versions of Ziana and Zyclara Valeant Pharmaceuticals International, April 11, 2013 Free full text
5 Bristol-Myers Squibb and Pfizer Announce Publication of ARISTOTLE Subanalysis in Circulation Bristol Myers-Squibb, May 10, 2013 Free full text
6 Novartis wins GBCHealth Business Action on Health Award for social ventures initiative Novartis, May 20, 2013 Free full text
7 Actavis to acquire warner chilcott BioPharm International, May 29, 2013 Free full text
8 Actavis Acquires Worldwide Rights for Valeants Metronidazole 1.3% Vaginal Gel Valeant Pharmaceuticals International, May 2, 2013 Free full text
Indexed Journals in Pharma News: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close